Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices

Clinical Cardiology

Volumn 28, Issue SUPPL., 2005, Pages 51-57

  Naccarelli, Gerald V ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy; CRT; ICD; Implantable cardioverter defibrillator; Left ventricular dysfunction; Ventricular arrhythmia

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; EPLERENONE; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN; SOTALOL; SPIRONOLACTONE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FOLLOW UP; HEALTH CARE COST; HEART ASSIST DEVICE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; MEDICAID; MEDICARE; META ANALYSIS; PRIMARY PREVENTION; QRS COMPLEX; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SUDDEN DEATH; SYSTEMATIC REVIEW; TREATMENT INDICATION;

EID: 27744484810     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960281309     Document Type: Review

References (25)

1. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In Heart Disease: A Textbook of Cardiovascular Medicine. pp. 890-932 (Eds. Braunwald E, Zipes DP, Libby P). Philadelphia: WB Saunders, 2001
2. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993;87:312-322
3. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 1989;321:406-412
4. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996;348:7-12
5. Julian DG, Prescott RJ, Jackson FS, Szekely P: Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982;1:1142-1147
6. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-674
7. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ: Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999;341:857-865
8. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-1583
9. Bigger JT Jr, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB, Steinman RC, Estes NA III: Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99:1416-1421
10. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940
11. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
12. Moss AJ: Implantable cardioverter defibrillator therapy: The sickest patients benefit the most. Circulation 2000;101:1638-1640
13. Zareba W: Late-breaking clinical trials: Noninvasive electrocardiology and outcome in MADIT-II patients. Available at: http://naspehighlights.org/ summary/summary.asp?sid=1&stid=19 &1d=2002-05-11. Accessed September 21,2005
14. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890
15. The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993;329:673-682
16. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. J Am Med Assoc 2002;288:3115-3123
17. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ: Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488
18. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
19. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM: Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
20. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549
21. Centers for Medicare & Medicaid Services: Decision memo for implantable defibrillators. Available at: http://www.cms.hhs.gov/mcd/ viewdecisionmemo.asp?id=148. Accessed September 21, 2005
22. American Heart Association: 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association, 2001
23. Behrens S: Identification of post-MI patients at high risk for sudden cardiac death in daily practice-first results of the prospective preSCD registry based on > 4000 patients. Presented at: North American Society of Pacing and Electrophysiology 24th Annual Scientific Sessions; May 14-17,2003; Washington, DC
24. Moss AJ: Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter- defibrillator. Circulation 2005;111:2537-2549
25. Delacretaz E, Schlaepfer J, Metzger J, Fromer M, Kappenberger L: Evidence rather than costs must guide use of the implantable cardioverter defibrillator. Am J Cardiol 2000;86:K52-K57